{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Nutriband, Inc. Stock Hits New 52-Week Low at $3.06
Nutriband, Inc. has reached a new 52-week low, reflecting ongoing financial struggles with negative results over three consecutive quarters. The company reported a significant decline in net sales and a substantial loss in net profit, alongside a low return on equity and underperformance compared to the S&P 500.
Nutriband, Inc. Stock Plummets to New 52-Week Low of $3.28
Nutriband, Inc. has reached a new 52-week low, reflecting ongoing challenges in the Pharmaceuticals & Biotechnology sector. The company reported a significant decline in net sales and a substantial net profit loss, alongside negative return on equity, raising concerns about its financial health amid a difficult operating environment.
Nutriband, Inc. Stock Plummets to New 52-Week Low of $3.38
Nutriband, Inc. has reached a new 52-week low, reflecting ongoing challenges in the Pharmaceuticals & Biotechnology sector. The company has experienced significant stock decline, negative return on equity, and concerning operating cash flow, alongside rising raw material costs, highlighting the difficulties faced by microcap stocks in today's market.
Nutriband, Inc. Stock Plummets to New 52-Week Low of $3.42
Nutriband, Inc. has reached a new 52-week low, reflecting ongoing financial difficulties. With a market capitalization of USD 46 million, the company faces challenges such as a negative return on equity and substantial losses. Rising raw material costs and significant underperformance in stock returns further complicate its situation.
Nutriband Forms Death Cross, Signaling Potential Bearish Trend Ahead
Nutriband, Inc. has encountered a significant technical event known as a Death Cross, indicating a potential shift in market sentiment. Current indicators reflect a bearish outlook, with recent performance challenges despite a year-to-date gain. The company's financial health is under scrutiny as investors watch for future developments.
Nutriband Stock Forms Death Cross, Signaling Bearish Trend Ahead
Nutriband, Inc. has recently encountered a technical event known as a Death Cross, indicating a potential shift in market sentiment. Current indicators reflect a bearish outlook, with significant declines over the past month and year-to-date performance lagging behind the broader market, raising concerns about its financial health.
Is Nutriband, Inc. overvalued or undervalued?
As of October 5, 2023, Nutriband, Inc. is considered undervalued with a P/E ratio of 12.5 and a P/B ratio of 1.8, indicating an attractive investment compared to peers, and its recent stock performance suggests the market may not fully recognize its growth potential.
Is Nutriband, Inc. technically bullish or bearish?
As of October 5, 2023, there is insufficient technical data for Nutriband, Inc. to determine if it is bullish or bearish.
What does Nutriband, Inc. do?
Nutriband, Inc. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, reporting net sales of $1 million and a net loss of $1 million as of April 2025. Key financial metrics include a market cap of $86.44 million, a P/E ratio of NA, and a dividend yield of 0.00%.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
